These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23529793)

  • 21. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.
    Mori K; Le Goff B; Charrier C; Battaglia S; Heymann D; Rédini F
    Bone; 2007 Apr; 40(4):981-90. PubMed ID: 17196895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of RANKL delivery to the osteoclast precursor cell surface.
    Honma M; Ikebuchi Y; Suzuki H
    J Bone Miner Metab; 2021 Jan; 39(1):27-33. PubMed ID: 33047191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
    Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
    J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scl-Ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes.
    Allison H; Holdsworth G; McNamara LM
    BMC Mol Cell Biol; 2020 Nov; 21(1):78. PubMed ID: 33148174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment.
    Arai A; Mizoguchi T; Harada S; Kobayashi Y; Nakamichi Y; Yasuda H; Penninger JM; Yamada K; Udagawa N; Takahashi N
    J Cell Sci; 2012 Jun; 125(Pt 12):2910-7. PubMed ID: 22454522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease.
    Bondar C; Ormazabal M; Crivaro A; Ferreyra-Compagnucci M; Delpino MV; Rozenfeld PA; Mucci JM
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irradiation-induced osteocyte damage promotes HMGB1-mediated osteoclastogenesis in vitro.
    He F; Bai J; Wang J; Zhai J; Tong L; Zhu G
    J Cell Physiol; 2019 Aug; 234(10):17314-17325. PubMed ID: 30786022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tartrate-resistant acid phosphatase (TRAP) co-localizes with receptor activator of NF-KB ligand (RANKL) and osteoprotegerin (OPG) in lysosomal-associated membrane protein 1 (LAMP1)-positive vesicles in rat osteoblasts and osteocytes.
    Solberg LB; Stang E; Brorson SH; Andersson G; Reinholt FP
    Histochem Cell Biol; 2015 Feb; 143(2):195-207. PubMed ID: 25201349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-κB in collagen-induced arthritis and bone marrow-derived macrophages.
    Huh JE; Jung IT; Choi J; Baek YH; Lee JD; Park DS; Choi DY
    Eur J Pharmacol; 2013 Jan; 698(1-3):57-66. PubMed ID: 22985747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vibration enhances osteoclastogenesis by inducing RANKL expression via NF-κB signaling in osteocytes.
    Sakamoto M; Fukunaga T; Sasaki K; Seiryu M; Yoshizawa M; Takeshita N; Takano-Yamamoto T
    Bone; 2019 Jun; 123():56-66. PubMed ID: 30902792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rab27a and Rab27b are involved in stimulation-dependent RANKL release from secretory lysosomes in osteoblastic cells.
    Kariya Y; Honma M; Hanamura A; Aoki S; Ninomiya T; Nakamichi Y; Udagawa N; Suzuki H
    J Bone Miner Res; 2011 Apr; 26(4):689-703. PubMed ID: 20939018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
    Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.
    Kim HN; Ha H; Lee JH; Jung K; Yang D; Woo KM; Lee ZH
    Eur J Pharmacol; 2009 Nov; 623(1-3):22-9. PubMed ID: 19766111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of TNF-
    Ohori F; Kitaura H; Marahleh A; Kishikawa A; Ogawa S; Qi J; Shen WR; Noguchi T; Nara Y; Mizoguchi I
    J Immunol Res; 2019; 2019():9716758. PubMed ID: 31341915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positive regulation of osteoclastic differentiation by growth differentiation factor 15 upregulated in osteocytic cells under hypoxia.
    Hinoi E; Ochi H; Takarada T; Nakatani E; Iezaki T; Nakajima H; Fujita H; Takahata Y; Hidano S; Kobayashi T; Takeda S; Yoneda Y
    J Bone Miner Res; 2012 Apr; 27(4):938-49. PubMed ID: 22190281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.
    Merle B; Itzstein C; Delmas PD; Chenu C
    J Cell Biochem; 2003 Oct; 90(2):424-36. PubMed ID: 14505357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of RANKL-induced osteoclastogenesis by TGF-β through molecular interaction between Smad3 and Traf6.
    Yasui T; Kadono Y; Nakamura M; Oshima Y; Matsumoto T; Masuda H; Hirose J; Omata Y; Yasuda H; Imamura T; Nakamura K; Tanaka S
    J Bone Miner Res; 2011 Jul; 26(7):1447-56. PubMed ID: 21305609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.